UBS O'Connor’s LeonaBio Inc LONA Stock Holding History

UBS O'Connor’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,519	Closed	-$290K	–	963
2022 Q2	$290K	Sell	9,519 -281	-3%	-$25.8K	﹤0.01%	840
2022 Q1	$1.32M	Buy	+9,800	New	+$1.03M	0.01%	653

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS O'Connor's LONA Position: Q3 2022 in Review

UBS O'Connor sold out of LeonaBio Inc (LONA) in Q3 2022, closing a stake of 9,519 shares — an estimated $290K sold.

UBS O'Connor first reported a position in LONA in Q1 2022 and held it in 2 quarters. The position peaked at $1.32M in Q1 2022. 98 funds tracked by Wall St. Rank hold LONA as of Q3 2022.

UBS O'Connor reported no remaining LeonaBio Inc position as of Q3 2022 after selling out during the quarter.
UBS O'Connor sold 9,519 LeonaBio Inc shares in Q3 2022, an estimated $290K.
UBS O'Connor first reported a position in LeonaBio Inc in Q1 2022 and held it in 2 quarters.
UBS O'Connor's LeonaBio Inc position peaked at $1.32M in Q1 2022.
98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2022.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.